NCT02407808Active, not recruitingPhase 1
Cannabinoids, Learning, and Memory
Source: ClinicalTrials.gov · Last updated 29 Apr 2026
Brief summary (registry, in English)
The overarching goal of this study is to characterize the effects of cannabinoids on working and episodic memory.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 31 Mar 2015
- Start date
- 1 Feb 2015
- Primary completion date
- 10 Aug 2018
- Lead sponsor
- Yale University
- NCT number
- NCT02407808
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 80
- From 1 Feb 2015 to the primary completion date, 10 Aug 2018
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Cannabis naive
- Positive pregnancy screen during screening
- Hearing deficits
Who the study is looking for
- Men and women aged 18 and 55 years (extremes included) on day of first dosing
- Exposed to cannabis at least once in their lifetime
Age in the registry: 18 years to 55 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| VA Connecticut Healthcare System Coordinator of this site? Confirm its status | West Haven | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.